Patents by Inventor Jurre Kamphorst

Jurre Kamphorst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220031646
    Abstract: Methods and compositions for treating cancer and other disorders associated with undesired cellular proliferation are provided comprising administering to a subject in need thereof an amino acid mixture, wherein the amino acid mixture comprises glycine, optionally comprising at least a 2:1 molar ratio of glycine to serine.
    Type: Application
    Filed: October 15, 2021
    Publication date: February 3, 2022
    Inventors: Joshua D. Rabinowitz, Craig B. Thompson, Jiangbin Ye, Jing Fan, Jurre Kamphorst
  • Patent number: 11147784
    Abstract: Methods and compositions for treating cancer and other disorders associated with undesired cellular proliferation are provided comprising administering to a subject in need thereof an amino acid mixture, wherein the amino acid mixture comprises glycine, optionally comprising at least a 2:1 molar ratio of glycine to serine.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: October 19, 2021
    Assignees: THE TRUSTEES OF PRINCETON UNIVERSITY, MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Joshua D. Rabinowitz, Craig B. Thompson, Jiangbin Ye, Jing Fan, Jurre Kamphorst
  • Patent number: 10772862
    Abstract: Methods and compositions for treating Ras-related cancers are provided that involve targeting lipid scavenging. Methods and compositions for identifying and/or characterizing more or less responsive cancers are also provided.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: September 15, 2020
    Assignees: The Trustees of Princeton University, Memorial Sloan Kettering Cancer Center
    Inventors: Joshua Rabinowitz, Jurre Kamphorst, Craig Thompson, Justin Cross
  • Publication number: 20190209503
    Abstract: Methods and compositions for treating cancer and other disorders associated with undesired cellular proliferation are provided comprising administering to a subject in need thereof an amino acid mixture, wherein the amino acid mixture comprises glycine, optionally comprising at least a 2:1 molar ratio of glycine to serine.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 11, 2019
    Inventors: Joshua D. Rabinowitz, Craig B. Thompson, Jiangbin Ye, Jing Fan, Jurre Kamphorst
  • Publication number: 20190046489
    Abstract: Methods and compositions for treating Ras-related cancers are provided that involve targeting lipid scavenging. Methods and compositions for identifying and/or characterizing more or less responsive cancers are also provided.
    Type: Application
    Filed: October 15, 2018
    Publication date: February 14, 2019
    Inventors: Joshua Rabinowitz, Jurre Kamphorst, Craig Thompson, Justin Cross
  • Patent number: 10130600
    Abstract: Methods and compositions for treating Ras-related cancers are provided that involve targeting lipid scavenging. Methods and compositions for identifying and/or characterizing more or less responsive cancers are also provided.
    Type: Grant
    Filed: May 9, 2014
    Date of Patent: November 20, 2018
    Assignees: Memorial Sloan Kettering Cancer Center, The Trustees of Princeton University
    Inventors: Joshua Rabinowitz, Jurre Kamphorst, Craig Thompson, Justin Cross
  • Publication number: 20160374971
    Abstract: Methods and compositions for treating cancer and other disorders associated with undesired cellular proliferation are provided comprising administering to a subject in need thereof an amino acid mixture, wherein the amino acid mixture comprises glycine, optionally comprising at least a 2:1 molar ratio of glycine to serine.
    Type: Application
    Filed: July 1, 2014
    Publication date: December 29, 2016
    Inventors: Joshua D. Rabinowitz, Craig B. Thompson, Jianbin Ye, Jing Fan, Jurre Kamphorst
  • Publication number: 20160120832
    Abstract: Methods and compositions for treating Ras-related cancers are provided that involve targeting lipid scavenging. Methods and compositions for identifying and/or characterizing more or less responsive cancers are also provided.
    Type: Application
    Filed: May 9, 2014
    Publication date: May 5, 2016
    Applicants: Memorial Sloan Kettering Cancer Center, The Trustees of Princeton Univeristy
    Inventors: Joshua Rabinowitz, Jurre Kamphorst, Craig Thompson, Justin Cross